ACQUISITION METHOD, COMPUTATION METHOD, EVALUATION DEVICE, COMPUTATION DEVICE, EVALUATION PROGRAM, COMPUTATION PROGRAM, AND EVALUATION SYSTEM

• Main Authors: NISHIKATA NATSUMI, ARASHIDA NAOKO, NAKAMURA HIDEHIRO, NISHIMOTO RUMI, IMAIZUMI AKIRA, SHINPO KAZUTAKA
• Format: Patent
• Language: English; Japanese
• Published: 19.07.2023
• Subjects: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES; MEASURING; PHYSICS; TESTING

To provide an evaluation method which allows for providing highly reliable information that could be helpful in knowing the state of pancreatic cancer, and to provide other inventions associated therewith.SOLUTION: An evaluation method according to an embodiment involves evaluating the state of pancreatic cancer in a subject using a concentration level(s) of at least one of N-Me-bABA, bABA, GABA, N6-Acetyl-L-Lys, 1-Me-His, aABA, Aminoadipic acid, bAiBA, Cadaverine, Ethylglycine, Homoarginine, Hypotaurine, Kinurenine, Putrescine, Serotonin, Spermidine, Spermine, ADMA, Homocitrulline, 3-Me-His, Hydroxyproline, Phosphoethanolamine, Acylcarnitine(13:1), and EPA in blood of the subject.SELECTED DRAWING: Figure 1 【課題】膵臓癌の状態を知る上で参考となり得る信頼性の高い情報を提供することができる評価方法などを提供することを課題とする。【解決手段】本実施形態では、評価対象の血液中のＮ－Ｍｅ－ｂＡＢＡ，ｂＡＢＡ，ＧＡＢＡ，Ｎ６－Ａｃｅｔｙｌ－Ｌ－Ｌｙｓ，１－Ｍｅ－Ｈｉｓ，ａＡＢＡ，Ａｍｉｎｏａｄｉｐｉｃ ａｃｉｄ，ｂＡｉＢＡ，Ｃａｄａｖｅｒｉｎｅ，Ｅｔｈｙｌｇｌｙｃｉｎｅ，Ｈｏｍｏａｒｇｉｎｉｎｅ，Ｈｙｐｏｔａｕｒｉｎｅ，Ｋｉｎｕｒｅｎｉｎｅ，Ｐｕｔｒｅｓｃｉｎｅ，Ｓｅｒｏｔｏｎｉｎ，Ｓｐｅｒｍｉｄｉｎｅ，Ｓｐｅｒｍｉｎｅ，ＡＤＭＡ，Ｈｏｍｏｃｉｔｒｕｌｌｉｎｅ，３－Ｍｅ－Ｈｉｓ，Ｈｙｄｒｏｘｙｐｒｏｌｉｎｅ，Ｐｈｏｓｐｈｏｅｔｈａｎｏｌａｍｉｎｅ，Ａｃｙｌｃａｒｎｉｔｉｎｅ（１３：１），ＥＰＡのうちの少なくとも１つの濃度値を用いて、評価対象について、膵臓癌の状態を評価する。【選択図】図１